Multiply Guaranteed Catalytic DNA Circuit for Cancer-Cell-Selective Imaging of miRNA and Robust Evaluation of Drug Resistance

Catalytic DNA circuits are desirable for sensitive bioimaging in living cells; yet, it remains a challenge to monitor these intricate signal communications because of the uncontrolled circuitry leakage and insufficient cell selectivity. Herein, a simple yet powerful DNA-repairing enzyme (APE1) activation strategy is introduced to achieve the site-specific exposure of a catalytic DNA circuit for realizing the selectively amplified imaging of intracellular microRNA and robust evaluation of the APE1-involved drug resistance. Specifically, the circuitry reactants are firmly blocked by the enzyme recognition/cleavage site to prevent undesirable off-site circuitry leakage. The caged DNA circuit has no target-sensing activity until its circuitry components are activated via the enzyme-mediated structural reconstitution and finally transduces the amplified fluorescence signal within the miRNA stimulation. The designed DNA circuit demonstrates an enhanced signal-to-background ratio of miRNA assay as compared with the conventional DNA circuit and enables the cancer-cell-selective imaging of miRNA. In addition, it shows robust sensing performance in visualizing the APE1-mediated chemoresistance in living cells, which is anticipated to achieve in-depth clinical diagnosis and chemotherapy research.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:96

Enthalten in:

Analytical chemistry - 96(2024), 14 vom: 09. Apr., Seite 5560-5569

Sprache:

Englisch

Beteiligte Personen:

Wang, Zeyue [VerfasserIn]
Shang, Yu [VerfasserIn]
Zhu, Yuxuan [VerfasserIn]
He, Yuqiu [VerfasserIn]
Chen, Yingying [VerfasserIn]
Liu, Xiaoqing [VerfasserIn]
Wang, Fuan [VerfasserIn]

Links:

Volltext

Themen:

9007-49-2
DNA
DNA, Catalytic
Journal Article
MicroRNAs

Anmerkungen:

Date Completed 10.04.2024

Date Revised 10.04.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1021/acs.analchem.4c00018

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM370192109